Literature DB >> 2680792

Therapeutic potential of a long acting somatostatin analogue in gastrointestinal diseases.

L J O'Donnell1, M J Farthing.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2680792      PMCID： PMC1434261          DOI： 10.1136/gut.30.9.1165

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  60 in total

1.  Proceedings: Effect of somatostatin on motilin levels and gastric emptying.

Authors:  S R Bloom; D N Ralphs; G M Besser; R Hall; D H Coy; A J Kastin; A V Schally
Journal:  Gut       Date:  1975-10       Impact factor: 23.059

2.  Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue.

Authors:  L K Kvols; C G Moertel; M J O'Connell; A J Schutt; J Rubin; R G Hahn
Journal:  N Engl J Med       Date:  1986-09-11       Impact factor: 91.245

3.  Stimulatory and inhibitory effects of purified hypothalamic extracts on growth hormone release from rat pituitary in vitro.

Authors:  L Krulich; A P Dhariwal; S M McCann
Journal:  Endocrinology       Date:  1968-10       Impact factor: 4.736

4.  Effect of a long-acting somatostatin analogue (SMS 201-995) on postprandial gastric emptying of 99mTc-tin colloid and mouth-to-caecum transit time in man.

Authors:  H S Fuessl; G Carolan; G Williams; S R Bloom
Journal:  Digestion       Date:  1987       Impact factor: 3.216

5.  Treatment of enterocutaneous fistulas with somatostatin.

Authors:  P Hild; J Dobroschke; K Henneking; B Rieck
Journal:  Lancet       Date:  1986-09-13       Impact factor: 79.321

6.  Modulation of functional gastrointestinal endocrine tumors by endogenous and exogenous somatostatin.

Authors:  E C Ellison; T M O'Dorisio; G D Benson
Journal:  Am J Surg       Date:  1986-06       Impact factor: 2.565

7.  Somatostatin: abundance of immunoreactive hormone in rat stomach and pancreas.

Authors:  A Arimura; H Sato; A Dupont; N Nishi; A V Schally
Journal:  Science       Date:  1975-09-19       Impact factor: 47.728

8.  Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.

Authors:  P Brazeau; W Vale; R Burgus; N Ling; M Butcher; J Rivier; R Guillemin
Journal:  Science       Date:  1973-01-05       Impact factor: 47.728

9.  Effects of somatostatin on exocrine and endocrine pancreatic function stimulated by intestinal hormones in man.

Authors:  H C Dollinger; S Raptis; E F Pfeiffer
Journal:  Horm Metab Res       Date:  1976-01       Impact factor: 2.936

10.  Gallstones, cholecystectomy, and duodenogastric reflux of bile acid.

Authors:  J O Svensson; J Gelin; J Svanvik
Journal:  Scand J Gastroenterol       Date:  1986-03       Impact factor: 2.423
View more
  7 in total

Review 1.  Therapeutic value of octreotide for patients with severe dumping syndrome--a review of randomised controlled trials.

Authors:  J Li-Ling; M Irving
Journal:  Postgrad Med J       Date:  2001-07       Impact factor: 2.401

2.  Effects of Zusanli electroacupuncture on somatostatin expression in the rat brainstem.

Authors:  Qinghua Tian; Lihua Wang; Lifen Yao; Liming Zhang; Huixue Zhang
Journal:  J Mol Neurosci       Date:  2012-06-29       Impact factor: 3.444

3.  Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects.

Authors:  T Kissel; J Drewe; S Bantle; A Rummelt; C Beglinger
Journal:  Pharm Res       Date:  1992-01       Impact factor: 4.200

4.  Duodenal varices. A neglected cause of massive, recurrent gastrointestinal bleeding.

Authors:  H B Chandra-Sekhar; E M Alstead; P J Kumar; M J Farthing
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

Review 5.  Octreotide, a long-acting somatostatin analog, in the management of postoperative dumping syndrome. An update.

Authors:  C B Lamers; A M Bijlstra; A G Harris
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

6.  Acrokeratosis paraneoplastica of Bazex in association with a metastatic neuroendocrine tumour.

Authors:  S M Halpern; L J O'Donnell; C N Makunura
Journal:  J R Soc Med       Date:  1995-06       Impact factor: 5.344

7.  Hepatic Cyst Infection During Use of the Somatostatin Analog Lanreotide in Autosomal Dominant Polycystic Kidney Disease: An Interim Analysis of the Randomized Open-Label Multicenter DIPAK-1 Study.

Authors:  Marten A Lantinga; Hedwig M A D'Agnolo; Niek F Casteleijn; Johan W de Fijter; Esther Meijer; Annemarie L Messchendorp; Dorien J M Peters; Mahdi Salih; Edwin M Spithoven; Darius Soonawala; Folkert W Visser; Jack F M Wetzels; Robert Zietse; Joost P H Drenth; Ron T Gansevoort
Journal:  Drug Saf       Date:  2017-02       Impact factor: 5.606
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.